Formulation development and pharmacokinetic studies of long acting in situ depot injection of risperidone
Abstract Risperidone is an atypical antipsychotic drug widely prescribed all over the world due to its clinical advantages. The currently available long acting marketed depot formulation of risperidone is a microsphere based preparation using poly-[lactide-co-glycolide] (PLGA) as drug release barrie...
Saved in:
Main Authors: | Vineet Dubey (Author), Tulsi Ram Saini (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits
by: Seyedeh Nesa Rezaeian Shiadeh, et al.
Published: (2023) -
Poly(ethylene glycol)-<i>b</i>-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables
by: Marie-Emérentienne Cagnon, et al.
Published: (2021) -
Development and Evaluation of a Water-Free In Situ Depot Gel Formulation for Long-Acting and Stable Delivery of Peptide Drug ACTY116
by: Yingxin Xiong, et al.
Published: (2024) -
The cost associated with administering risperidone long-acting injections in the Australian community
by: Hertel Judy, et al.
Published: (2011) -
An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot Systems
by: Dileep R. Janagam, et al.
Published: (2016)